Multiple activities in lantibiotics--models for the design of novel antibiotics?
about
Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insightsComplete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus speciesEvolution of lanthipeptide synthetasesLanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionAntimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryBioengineering Lantibiotics for Therapeutic SuccessRelatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.Biosynthesis and regulation of grisemycin, a new member of the linaridin family of ribosomally synthesized peptides produced by Streptomyces griseus IFO 13350.Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters.Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptidesWhen the leader gets loose: in vivo biosynthesis of a leaderless prenisin is stimulated by a trans-acting leader peptide.Investigating the importance of charged residues in lantibiotics.Nine post-translational modifications during the biosynthesis of cinnamycin.DAMPD: a manually curated antimicrobial peptide database.Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells.Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI.Morphogenetic surfactants and their role in the formation of aerial hyphae in Streptomyces coelicolor.Synthesis of pdCpAs and transfer RNAs activated with thiothreonine and derivatives.Bacteriocin diversity in Streptococcus and Enterococcus.Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity.Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis.In vitro reconstitution and substrate specificity of a lantibiotic protease.The dual role of bacteriocins as anti- and probiotics.Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.Lantibiotics as probes for phosphatidylethanolamine.The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.Increasing the success rate of lantibiotic drug discovery by Synthetic Biology.Trends in utilization of agro-industrial byproducts for production of bacteriocins and their biopreservative applications.The lantibiotic mersacidin is an autoinducing peptide.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.cDNA cloning and molecular characterization of a defensin-like antimicrobial peptide from larvae of Protaetia brevitarsis seulensis (Kolbe).Pinensins: the first antifungal lantibiotics.Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37.Identification of a nisI promoter within the nisABCTIP operon that may enable establishment of nisin immunity prior to induction of the operon via signal transduction.Lantibiotic transporter requires cooperative functioning of the peptidase domain and the ATP binding domain.Effect of lantibiotic gallidermin against biogenic amine-producing faecal staphylococci from ostriches and pheasants.In vivo activity of mutacin B-Ny266.ATPase activity regulation by leader peptide processing of ABC transporter maturation and secretion protein, NukT, for lantibiotic nukacin ISK-1.
P2860
Q21145797-97022CFD-6592-45E8-A164-CBC866BA9F09Q21194862-45897C93-D8F1-4914-9860-08A9D62EEB9CQ24615015-E3B32BD4-42D0-4E48-9833-863C70A8A4B2Q26748638-870972AB-A8D1-4F74-A898-350F09B2C5A7Q26751499-DDAB9735-BB8D-45F8-B8BD-6C674635133AQ26774123-D4677DCE-AF39-49BA-AEEB-C584793C7D4CQ33281068-AF67B4FD-57E2-4A85-9159-ED099EA674C5Q33850997-BB830409-89B1-48D3-99CB-467DF7B8F653Q33961416-08897D3F-FB8D-48F8-B56F-4B1E73148037Q34135012-572181A3-DAAE-468B-AC25-E90D9339F9E0Q34446536-5BFA4E35-0008-4198-9729-A4FCEEA79F6AQ34568188-D7299299-363B-4D80-B6E8-4968930DD375Q35185462-F72CFEB0-15F8-4F54-9AF8-CBDB94151B19Q35630683-B12D3517-F30F-498C-BD6C-5E6864CF0979Q35754137-6ECD6E8F-01D7-46E2-972C-C8D23DA9552AQ36276875-DC4F266D-6D7E-471D-A098-BB2D4406F5D0Q36371636-2420A06F-B70B-4F08-AA6E-0D8B87EF2D59Q36617647-4F09907B-4BBD-43CF-B8D0-8C622A869048Q36651005-2707E5EB-C94F-44DE-A4D7-3CE99D2D11CFQ36839131-4502C4E5-9FA3-4D3D-98E5-34F4051D8900Q36839135-71F4A194-0BEA-4656-A171-9DB16EF60E1DQ36952065-BCA8D4B2-1A29-47A8-B074-62B1C4DBB298Q37160785-7B4AB2F0-FBD3-4AD1-A209-3003E3999FBBQ37332509-ADA4A2B0-B4A2-460D-94CF-E0AB0B3CA9B9Q37333234-4D98B161-D8D2-4E59-B714-81DC92F4086AQ37400823-07E19A5A-8079-46E7-9367-C0CBDBB99AC6Q37940910-C7EA8C71-16E4-40FF-9995-45E9698E552AQ38014580-CB464558-9EEE-4577-9BBA-760F9CAB2EBCQ38017216-14734ECB-D5EB-4448-A683-33BECF6A7D6AQ38272181-C98C11D5-F5CB-46D1-896B-6ED5BC935FEFQ39108016-D09BB4C7-463E-4440-90FB-0BE4ED2BC31CQ39109460-6BAE0CB6-80AC-47AB-B4AD-0638868347ABQ39925720-DDA2E50A-ECFD-4D5B-9DB2-AEEDBC26BACAQ40695785-1D1E054B-7925-4963-8BEF-A1547EAEC0A8Q41007953-1195439E-0584-4717-8CE2-25E429751B7FQ41063997-3D11E444-E346-4496-89CE-F592439C668DQ42703669-41CCF5DE-9B16-4453-9FBA-96B1727F7C0BQ46433039-B782E749-B861-4450-8DD2-8FAE5E68A5E5Q46696994-49338181-584F-4981-9F10-BA3DB292B308Q47371883-70667755-06C7-409E-9F1E-5A88DB8B6C19
P2860
Multiple activities in lantibiotics--models for the design of novel antibiotics?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@ast
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@en
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@nl
type
label
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@ast
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@en
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@nl
prefLabel
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@ast
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@en
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@nl
P356
P1476
Multiple activities in lantibiotics--models for the design of novel antibiotics?
@en
P304
P356
10.2174/1381612023395439
P577
2002-01-01T00:00:00Z